Trial Profile
LY2599506, a novel glucokinase activator (GKA), in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2011
Price :
$35
*
At a glance
- Drugs PSN 010 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 20 Sep 2011 New trial record